Curie Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Curie Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9322
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Curie Institute is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biology and developmental biology, among others. It provides services in the area such as genetics and carcinogenesis, cell and tissue imaging, and others. It offers care, research and training services for detecting, treating and monitoring cancer. Curie Institute provides services in anesthesia, medicine, pediatrics, surgery, tumor biology, intensive care, pain and medical imaging, among others. The foundation offers masters, PhD and postdoctoral fellowship programmes, and other courses. Curie Institute is headquartered in Paris, France.

Curie Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9
Curie Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Curie Institute, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Institut Curie Enters into Agreement with Pierre Fabre 12
Roche and Institut Curie Enter into Agreement 13
Institut Curie Enters into Collaboration Agreement with Epidemium 14
Ignyta and Institut Curie Enter into Partnership 15
Bristol-Myers Squibb Enters into Co-Development Agreement with Institut Curie 16
Celyad Enters into Partnership with Institut Curie 17
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 18
Curie-Cancer Partners with Inventiva 19
Institut Curie Extends Research Agreement with Servier 20
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 21
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 22
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 23
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 24
Licensing Agreements 25
Stimunity Enters into Licensing Agreement with Inserm Transfert and Institut Curie 25
Theravectys Enters into Licensing Agreement with Institut Curie 26
Abbott Molecular Enters into Licensing Agreement with Institut Curie 27
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 28
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 29
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 30
Curie Institute – Key Competitors 31
Curie Institute – Key Employees 32
Curie Institute – Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Strategy And Business Planning 34
Sep 17, 2018: Institut Curie announces creation of Honing Biosciences 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Curie Institute, Pharmaceuticals & Healthcare, Key Facts 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9
Curie Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Institut Curie Enters into Agreement with Pierre Fabre 12
Roche and Institut Curie Enter into Agreement 13
Institut Curie Enters into Collaboration Agreement with Epidemium 14
Ignyta and Institut Curie Enter into Partnership 15
Bristol-Myers Squibb Enters into Co-Development Agreement with Institut Curie 16
Celyad Enters into Partnership with Institut Curie 17
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 18
Curie-Cancer Partners with Inventiva 19
Institut Curie Extends Research Agreement with Servier 20
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 21
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 22
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 23
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 24
Stimunity Enters into Licensing Agreement with Inserm Transfert and Institut Curie 25
Theravectys Enters into Licensing Agreement with Institut Curie 26
Abbott Molecular Enters into Licensing Agreement with Institut Curie 27
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 28
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 29
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 30
Curie Institute, Key Competitors 31
Curie Institute, Key Employees 32

List of Figures
Curie Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Curie Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curie Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Curie Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curie Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curie Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Curie Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pfizer Inc (PFE):製薬・医療:M&Aディール及び事業提携情報
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • Kumiai Chemical Industry Co Ltd (4996):企業の財務・戦略的SWOT分析
    Summary Kumiai Chemical Industry Co Ltd (Kumiai Chemical) operates as a chemical company that develops, manufactures and markets agricultural chemicals, fine chemicals, and curing agents. The company's agricultural chemicals include bactericides, herbicides, fungicides, acaricides, microbial pestici …
  • Buckeye Partners, L.P.:企業の戦略・SWOT・財務情報
    Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Acxiom Corporation:企業の戦略・SWOT・財務情報
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • National Insurance Corporation of Eritrea Share Company:企業の戦略的SWOT分析
    National Insurance Corporation of Eritrea Share Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key c …
  • Mayo Clinic-医療機器分野:企業M&A・提携分析
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Capricor Therapeutics Inc (CAPR):企業の財務・戦略的SWOT分析
    Summary Capricor Therapeutics Inc (Capricor) is a biotechnology company that discovers, develops and commercializes biological therapeutics for the treatment of rare disorders. The company offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced …
  • Stresau Laboratory, Inc.:企業の戦略・SWOT・財務情報
    Stresau Laboratory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Stresau Laboratory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cafes Novell SA:企業の戦略・SWOT・財務分析
    Cafes Novell SA - Strategy, SWOT and Corporate Finance Report Summary Cafes Novell SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sunrise Senior Living LLC:戦略・SWOT・企業財務分析
    Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • LifeLabs Inc-医療機器分野:企業M&A・提携分析
    Summary LifeLabs Inc (LifeLabs) is a laboratory testing service provider that monitors heart disease and identifies neurological disorders and pinpoint allergies. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, me …
  • Clean Energy Fuels Corp (CLNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • The Siam Cement Public Co Ltd:企業の戦略・SWOT・財務情報
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務情報
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • OHB System AG:企業の戦略・SWOT・財務情報
    OHB System AG - Strategy, SWOT and Corporate Finance Report Summary OHB System AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析
    Summary ImmunoGen Inc (ImmunoGen) is a biotechnology company that carries out the development of anticancer therapeutics. The company uses its proprietary antibody-drug conjugates (ADC) technology for the development of the products. It develops products for the treatment of various types of cancer …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PartnerRe Ltd.:企業のM&A・事業提携・投資動向
    PartnerRe Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PartnerRe Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • U.S. Smokeless Tobacco Company:企業の戦略・SWOT・財務分析
    U.S. Smokeless Tobacco Company - Strategy, SWOT and Corporate Finance Report Summary U.S. Smokeless Tobacco Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Clientele Limited
    Clientele Limited - Strategy, SWOT and Corporate Finance Report Summary Clientele Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆